Name
dep_ssri_med
Label
Antidepressant, SSRI: Self-reported use
Description

Self reported drugs at PSG visit, open text then grouped according to effect

Domain
takingornot
  • 0: Not taking
  • 1: Taking
Type
choices
Antidepressant, SSRI: Self-reported use vs Study visit number
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5
Total 1,123 758 566 121 2
Not taking 963 644 483 103 -
Taking 160 114 83 18 2
Antidepressant, SSRI: Self-reported use vs Sex of the participant
Visit 1
Male Female Total
Total 608 515 1,123
Not taking 554 409 963
Taking 54 106 160
Antidepressant, SSRI: Self-reported use vs Sex of the participant
Visit 2
Male Female Total
Total 406 352 758
Not taking 372 272 644
Taking 34 80 114
Antidepressant, SSRI: Self-reported use vs Sex of the participant
Visit 3
Male Female Total
Total 304 262 566
Not taking 282 201 483
Taking 22 61 83
Antidepressant, SSRI: Self-reported use vs Sex of the participant
Visit 4
Male Female Total
Total 67 54 121
Not taking 63 40 103
Taking 4 14 18
Antidepressant, SSRI: Self-reported use vs Sex of the participant
Visit 5
Male Female Total
Total - 2 2
Not taking - - -
Taking - 2 2
Antidepressant, SSRI: Self-reported use vs Race of the participant
Visit 1
White Black Hispanic Native American Asian Total
Total 1,065 23 13 10 12 1,123
Not taking 911 21 12 9 10 963
Taking 154 2 1 1 2 160
Antidepressant, SSRI: Self-reported use vs Race of the participant
Visit 2
White Black Hispanic Native American Asian Total
Total 734 8 6 6 4 758
Not taking 621 7 6 6 4 644
Taking 113 1 - - - 114
Antidepressant, SSRI: Self-reported use vs Race of the participant
Visit 3
White Black Hispanic Native American Asian Total
Total 549 4 5 4 4 566
Not taking 468 3 4 4 4 483
Taking 81 1 1 - - 83
Antidepressant, SSRI: Self-reported use vs Race of the participant
Visit 4
White Black Hispanic Native American Asian Total
Total 113 1 2 2 3 121
Not taking 95 1 2 2 3 103
Taking 18 - - - - 18
Antidepressant, SSRI: Self-reported use vs Race of the participant
Visit 5
White Black Hispanic Native American Asian Total
Total 2 - - - - 2
Not taking - - - - - -
Taking 2 - - - - 2